|
|
 |
VOSEVI Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AMMONIO METHACRYLATE COPOLYMER TYPE B Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ALCOHOL Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
VIBERZI Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
VELTASSA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ANHYDROUS CITRIC ACID Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
VEKLURY Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
VARITHENA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
VENCLEXTA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|